MDM2 and cancer: ,90 In view of MDM2 playing a key role in regulating the growth, proliferation, and cell cycle progression of cancer cells, drugs targeting the ubiquitin-protease system of p53 and MDM2, such as ubiquitin-specific protease 7 (USP7) inhibitors and SP141 have a good prospect of therapy.8